Summit Speaker Spotlight: Tim Boyd From NORD

by | Aug 3, 2016 | 1 comment

Tim BoydThe availability of affordable healthcare is an issue that affects each and every one of us. This is even more critical for patients with rare diseases.

HNF has partnered with NORD to help us find the solutions and realize a brighter future for those living with CMT and other INs. We’ve invited Tim Boyd, Associate Director of State Policy, National Organization for Rare Disorders (NORD) to lead a discussion on Public Policy at the Summit.

According to Tim, the cost and availability of health care services for patients with a rare disease is dependent upon state-based policy decisions. The design of public and privately-funded health plans does not always take the needs of the rare community into account in determining benefits and costs.

Tim has served as NORD’s Associate Director of State Policy and Advocacy since 2015, and is responsible for their policy activity in all 50 states. Prior to that, he worked on federal and state public policy for eight years with the AIDS Healthcare Foundation (AHF). Tim earned his B.A. in Political Science from the University of California Santa Barbara and is an M.P.H. Candidate (2017) George Washington University Milken Institute of Public Health.

His goal for the Summit is to provide attendees with a sense of NORD’s perspective on state-based health care issues and inform them about ways they can engage with us on various initiatives.

We look forward to hearing from Tim and the panelists on what is sure to be an interesting and spirited discussion!

You can connect with Tim here:
Twitter: @rareaction, @rarediseases 

Learn more on this topic

Related Blog Posts

CMT Kids Video

The Hereditary Neuropathy Foundation is currently seeking 10 second video clips of CMT patients under the age of 16, performing daily activities.

Summit Panelist Spotlight: Mitchell Warner

Bracing is used in the management Charcot-Marie-Tooth to support and hold a part of the body compromised by muscle weakness, muscular atrophy, sensory impairment. Bracing is also used to help correct skeletal deformity.

Summit Panelist Spotlight: Brent Baker

With respect to CMT, Dr. Baker’s team has collaborated with Drs. Michael Sereda and Klaus Nave of the Max Planck Institute for Experimental Medicine (MPI) to utilize their CMT1A transgenic rat and established the initial CMT1A rat colony in the United States.

Join the conversation

Leave a Comment

1 Comment

  1. Shawna Davis

    I have a private HMO in San Diego Ca. I’m trying to get my insurance company to approve an out of network coverage to go to the center of excellence of Cedar Sini in LA. We have no specialist in San Diego. Do you have any idea if there is some kind of Advocacy group or anyone who might be able to help me in my insurance battle? I will be at the conference, maybe somebody there will know if such a group exist?


Submit a Comment

Your email address will not be published. Required fields are marked *


Join for notifications on events, campaigns, & news